Creative Financial Designs Inc Precigen, Inc. Transaction History

Creative Financial Designs Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$0.96 - $1.4 $960 - $1,400	-1,000 Reduced 50.0%	1,000 $1,000
Q3 2022 Nov 01, 2022	BUY	$1.41 - $2.79 $1,410 - $2,790	1,000 Added 100.0%	2,000 $4,000
Q2 2022 Aug 01, 2022	BUY	$1.15 - $2.53 $1,148 - $2,527	999 Added 99900.0%	1,000 $1,000
Q1 2022 Apr 15, 2022	SELL	$1.91 - $3.98 $1,910 - $3,980	-1,000 Reduced 99.9%	1 $0
Q4 2021 Jan 26, 2022	BUY	$3.53 - $5.5 $3,530 - $5,500	1,000 Added 100000.0%	1,001 $4,000
Q1 2021 Apr 19, 2021	BUY	$6.74 - $10.95 $6 - $10	1 New	1 $0

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $348M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.